ALPS ETF Trust has released its latest financial update, showcasing significant details about its assets and liabilities. This filing is essential for understanding the company's current financial health and its position within the investment industry.
Background
ALPS ETF Trust, identified under the Central Index Key (CIK) 0001414040, operates as an investment entity. The company is known for its focus on exchange-traded funds (ETFs) and is registered with the SEC under the Investment Company Act of 1940. The latest filing, dated October 29, 2026, is part of a series of NPORT-P submissions, which are designed to provide transparency regarding fund performance and asset management.
What the Filing Says
The recent filing indicates that ALPS ETF Trust has total assets amounting to approximately $240 million, with net assets reported at about $239.98 million. The filing also outlines the fund's total liabilities, which stand at approximately $95,695.35. Additionally, the fund's performance metrics include a monthly total return of 18.7% for the first month reported, followed by a slight decrease of 1.64% in the second month, and a recovery of 4.99% in the third month.
Impact
This update is significant for various stakeholders, including investors, analysts, and competitors in the investment sector. Investors will be keen to analyze the fund's performance and the implications for their investment strategies. Competitors will likely assess ALPS ETF Trust's asset management approach and performance metrics to gauge their own standing in the market.
What's Next
The filing does not specify what happens next, but it indicates a commitment to ongoing transparency and performance reporting. Stakeholders will await further updates and filings to continue monitoring the fund's trajectory.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






